"The more recent estimates say that as many as half of patients with metastatic HER2-positive disease will develop brain metastases over the course of their lifetime," said Nancy U. Lin, MD, of Dana-Farber Cancer Institute in Boston. https://www.medpagetoday.com/clinical-challenges/esmo-breast-cancer-her2/82681
I did not realise the figure was so high.
- Forums
- ASX - By Stock
- KZA
- San Antonio Breast Cancer Symposium 8 Dec
San Antonio Breast Cancer Symposium 8 Dec, page-25
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online